March 31 (Reuters) - Rani Therapeutics Holdings Inc RANI.O:
RANI THERAPEUTICS Q4 OPERATING EXPENSES USD 15.986 MILLION
RANI THERAPEUTICS Q4 OPERATING INCOME USD -14.958 MILLION
RANI THERAPEUTICS Q4 NET INCOME USD -15.721 MILLION
RANI THERAPEUTICS HOLDINGS: CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES SUFFICIENT TO FUND OPERATIONS INTO Q3
Q4 LOSS PER SHARE $0.27
Q4 EARNINGS PER SHARE VIEW $-0.25 -- LSEG IBES DATA
Source text: ID:nGNX5FWCml
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.